ABSTRACT
Many developmental syndromes have been linked to genetic mutations that cause abnormal ERK/MAPK activity; however, the neuropathological effects of hyperactive signaling are not fully understood. Here, we examined whether hyperactivation of MEK1 modifies the development of GABAergic cortical interneurons (CINs), a heterogeneous population of inhibitory neurons necessary for cortical function. We show that GABAergic-neuron specific MEK1 hyperactivation in vivo leads to increased cleaved caspase-3 labeling in a subpopulation of immature neurons in the embryonic subpallial mantle zone. Adult mutants displayed a significant loss of parvalbumin (PV), but not somatostatin, expressing CINs and a reduction in perisomatic inhibitory synapses on excitatory neurons. Surviving mutant PV-CINs maintained a typical fast-spiking phenotype but showed signs of decreased intrinsic excitability that coincided with an increased risk of seizure-like phenotypes. In contrast to other mouse models of PV-CIN loss, we discovered a robust increase in the accumulation of perineuronal nets, an extracellular structure thought to restrict plasticity. Indeed, we found that mutants exhibited a significant impairment in the acquisition of behavioral response inhibition capacity. Overall, our data suggest PV-CIN development is particularly sensitive to hyperactive MEK1 signaling, which may underlie certain neurological deficits frequently observed in ERK/MAPK-linked syndromes.
Subject(s)
Cerebral Cortex/embryology , Cerebral Cortex/metabolism , GABAergic Neurons/metabolism , Inhibition, Psychological , MAP Kinase Kinase 1/metabolism , Parvalbumins/metabolism , Animals , Cerebral Cortex/chemistry , Electroencephalography/methods , Embryonic Development/physiology , GABAergic Neurons/chemistry , Locomotion/physiology , MAP Kinase Kinase 1/analysis , Mice , Organ Culture Techniques , Parvalbumins/analysis , Signal Transduction/physiologyABSTRACT
We describe a convenient and simple continuous spectrophotometric method for the determination of mitogen-activated protein kinase (MAPK) kinase activity with its protein substrate. The assay relies on the measurement of phosphoprotein product generated in the first step of the MAPK kinase reaction. Dephosphorylation of the phosphoprotein is coupled to a MAPK phosphatase to generate phosphate, which is then used as the substrate of purine nucleoside phosphorylase to catalyze the N-glycosidic cleavage of 2-amino 6-mercapto 7-methyl purine ribonucleoside. Of the reaction products ribose 1-phosphate and 2-amino 6-mercapto 7-methylpurine, the latter has a high absorbance at 360nm relative to the nucleoside and, hence, provides a spectrophotometric signal that can be continuously followed. In the presence of excess phosphatase, the phosphorylated protein substrate molecules undergo dephosphorylation almost immediately after their formation; the steady-state use of the resultant inorganic phosphate is a reflection of the constant initial velocity of the exchange reaction. The validity of this method has been confirmed by using it to measure the activities of MEK1 (MAPK/ERK kinase 1) and MKK6 (MAPK kinase 6) toward their physiological substrates. Our findings of the MAPK kinases in the current study provide evidence that the substrate binding affinities of this subfamily of protein kinases are at the submicromolar concentration.
Subject(s)
Mitogen-Activated Protein Kinase Kinases/analysis , Spectrophotometry/methods , Dual Specificity Phosphatase 6/metabolism , Dual-Specificity Phosphatases/metabolism , Humans , Kinetics , MAP Kinase Kinase 1/analysis , MAP Kinase Kinase 1/metabolism , MAP Kinase Kinase 6/analysis , MAP Kinase Kinase 6/metabolism , Mitogen-Activated Protein Kinase Kinases/metabolism , Mitogen-Activated Protein Kinase Phosphatases/metabolism , Phosphorylation , Reproducibility of ResultsABSTRACT
Extracellular signal-regulated kinase (Erk) is widely recognized for its central role in cell proliferation and motility. Although previous work has shown that Erk is localized at endosomal compartments, no role for Erk in regulating endosomal trafficking has been demonstrated. Here, we report that Erk signaling regulates trafficking through the clathrin-independent, ADP-ribosylation factor 6 (Arf6) GTPase-regulated endosomal pathway. Inactivation of Erk induced by a variety of methods leads to a dramatic expansion of the Arf6 endosomal recycling compartment, and intracellular accumulation of cargo, such as class I major histocompatibility complex, within the expanded endosome. Treatment of cells with the mitogen-activated protein kinase kinase (MEK) inhibitor U0126 reduces surface expression of MHCI without affecting its rate of endocytosis, suggesting that inactivation of Erk perturbs recycling. Furthermore, under conditions where Erk activity is inhibited, a large cohort of Erk, MEK, and the Erk scaffold kinase suppressor of Ras 1 accumulates at the Arf6 recycling compartment. The requirement for Erk was highly specific for this endocytic pathway, because its inhibition had no effect on trafficking of cargo of the classical clathrin-dependent pathway. These studies reveal a previously unappreciated link of Erk signaling to organelle dynamics and endosomal trafficking.
Subject(s)
Clathrin/physiology , Endocytosis/physiology , Endosomes/physiology , Extracellular Signal-Regulated MAP Kinases/physiology , ADP-Ribosylation Factor 6 , ADP-Ribosylation Factors/metabolism , Biological Transport/drug effects , Biological Transport/physiology , Biomarkers , Butadienes/pharmacology , Cell Membrane/metabolism , Endocytosis/drug effects , Enzyme Inhibitors/pharmacology , Epistasis, Genetic , Extracellular Signal-Regulated MAP Kinases/antagonists & inhibitors , HeLa Cells , Histocompatibility Antigens Class I/metabolism , Humans , Kinetics , MAP Kinase Kinase 1/analysis , Nitriles/pharmacology , Protein Kinases/analysis , Protein Kinases/metabolism , Signal TransductionABSTRACT
Subcellular targeting of kinases controls their activation and access to substrates. Although Ca2+/calmodulin-dependent protein kinase II (CaMKII) is known to regulate differentiated smooth muscle cell (dSMC) contractility, the importance of targeting in this regulation is not clear. The present study investigated the function in dSMCs of a novel variant of the gamma isoform of CaMKII that contains a potential targeting sequence in its association domain (CaMKIIgamma G-2). Antisense knockdown of CaMKIIgamma G-2 inhibited extracellular signal-related kinase (ERK) activation, myosin phosphorylation, and contractile force in dSMCs. Confocal colocalization analysis revealed that in unstimulated dSMCs CaMKIIgamma G-2 is bound to a cytoskeletal scaffold consisting of interconnected vimentin intermediate filaments and cytosolic dense bodies. On activation with a depolarizing stimulus, CaMKIIgamma G-2 is released into the cytosol and subsequently targeted to cortical dense plaques. Comparison of phosphorylation and translocation time courses indicates that, after CaMKIIgamma G-2 activation, and before CaMKIIgamma G-2 translocation, vimentin is phosphorylated at a CaMKII-specific site. Differential centrifugation demonstrated that phosphorylation of vimentin in dSMCs is not sufficient to cause its disassembly, in contrast to results in cultured cells. Loading dSMCs with a decoy peptide containing the polyproline sequence within the association domain of CaMKIIgamma G-2 inhibited targeting. Furthermore, prevention of CaMKIIgamma G-2 targeting led to significant inhibition of ERK activation as well as contractility. Thus, for the first time, this study demonstrates the importance of CaMKII targeting in dSMC signaling and identifies a novel targeting function for the association domain in addition to its known role in oligomerization.
Subject(s)
Calcium-Calmodulin-Dependent Protein Kinases/physiology , Extracellular Signal-Regulated MAP Kinases/physiology , MAP Kinase Signaling System/physiology , Muscle, Smooth, Vascular/physiology , Actinin/analysis , Actinin/metabolism , Animals , COS Cells , Calcium-Calmodulin-Dependent Protein Kinase Type 2 , Calcium-Calmodulin-Dependent Protein Kinases/analysis , Calcium-Calmodulin-Dependent Protein Kinases/chemistry , Cell Differentiation , Ferrets , MAP Kinase Kinase 1/analysis , MAP Kinase Kinase 2/analysis , Muscle, Smooth, Vascular/cytology , Oligonucleotides, Antisense/pharmacology , Phosphorylation , Protein Structure, Tertiary , Protein Transport , Vasoconstriction , Vimentin/analysis , Vimentin/metabolismABSTRACT
Low-number transplantation of pancreatic islets into the livers of diabetic rats leads to transformation of the downstream liver acini into clear-cell foci of altered hepatocytes (FAHs). These FAHs correspond to the glycogen-storing (clear-cell) phenotype of hepatocellular preneoplasias and develop into hepatocellular adenomas (HCAs) and hepatocellular carcinomas (HCCs) within 6 to 24 months. In addition, they show metabolic alterations that resemble well-known insulin effects, most likely constituting the result of the local hyperinsulinemia. Thus, we investigated FAHs, HCAs, and HCCs for altered expression of insulin receptor, insulin receptor substrate-1 (IRS-1), Raf-1 and Mek-1. Light and electron microscopic immunohistochemistry revealed a translocation of insulin receptor from the plasma membrane (normal tissue) into the cytoplasm in clear-cell FAHs and an increase in insulin receptor expression in HCAs and HCCs. FAHs also showed an increase in IRS-1 gene expression, investigated by in situ hybridization and quantitative reverse transcription-PCR. IRS-1, Raf-1, and Mek-1 proteins were strongly overexpressed in FAHs and tumors, as compared with the unaltered liver tissue. These overexpressions were closely linked to the clear-cell phenotype of preneoplastic and neoplastic hepatocytes, because basophilic FAHs (later stages) and basophilic tumors showed no overexpressions. In this endocrine model of hepatocarcinogenesis, severe alterations of insulin signaling were induced by the pathological local action of islet hormones in the livers and may substantially contribute to the carcinogenic process.
Subject(s)
Diabetes Mellitus, Experimental/complications , Liver Neoplasms, Experimental/etiology , MAP Kinase Kinase 1/physiology , Phosphoproteins/physiology , Precancerous Conditions/etiology , Proto-Oncogene Proteins c-raf/physiology , Receptor, Insulin/physiology , Animals , Insulin Receptor Substrate Proteins , Islets of Langerhans Transplantation , MAP Kinase Kinase 1/analysis , Male , Phosphoproteins/analysis , Phosphoproteins/genetics , Proto-Oncogene Proteins c-raf/analysis , RNA, Messenger/analysis , Rats , Rats, Inbred Lew , Receptor, Insulin/analysis , Signal Transduction , StreptozocinABSTRACT
BACKGROUND: The extracellular-regulated protein kinase (ERK) pathway has been implicated in processes such as neuronal plasticity and resilience in psychiatric disorders including major depressive disorder (MDD), bipolar disorder (BPD), and schizophrenia. The extent of the possible involvement of this pathway in psychiatric disorders remains unknown, as does its potential utility as a pharmacological target for the future development of novel therapeutics. METHODS: Western blot analyses were used to measure levels of different proteins-Rap1, B-Raf, MEK1, MEK2, ERK1/2, RSK1, CREB, NSE, and beta-actin-in the postmortem frontal cortex of individuals with schizophrenia, MDD, and BPD, as well as healthy non-psychiatric controls. RESULTS: Levels of most studied protein members of the ERK cascade were lower in individuals with psychiatric disorders than controls; differences between psychiatric groups were not statistically significant. In general, protein levels were lower in individuals with schizophrenia than in those with BPD or MDD, but protein levels varied across groups. LIMITATIONS: The small number of individuals in each diagnostic group may limit our interpretation of the results. Factors such as postmortem interval, medication status at time of death, and mood state at time of death may also have influenced the findings. DISCUSSION: The results are consistent with the hypothesis that the ERK pathway is implicated in reduced neuronal plasticity associated with the course of these psychiatric illnesses. The results warrant an expanded investigation into the activity of other members of this pathway as well as other brain areas of interest.
Subject(s)
Bipolar Disorder/pathology , Depressive Disorder, Major/pathology , Extracellular Signal-Regulated MAP Kinases/analysis , Frontal Lobe/pathology , Schizophrenia/pathology , Actins/analysis , Adult , Blotting, Western , Cyclic AMP Response Element-Binding Protein/analysis , Female , Humans , MAP Kinase Kinase 1/analysis , MAP Kinase Kinase 2/analysis , Male , Middle Aged , Mitogen-Activated Protein Kinase 3/analysis , Neuronal Plasticity/physiology , Phosphopyruvate Hydratase/analysis , Proto-Oncogene Proteins B-raf/analysis , Reference Values , Ribosomal Protein S6 Kinases, 90-kDa/analysis , Shelterin Complex , Telomere-Binding Proteins/analysisABSTRACT
Our recent studies have shown that MEK1/2 is a critical regulator of microtubule organization and spindle formation during oocyte meiosis. In the present study, we found that Plk1 colocalized with p-MEK1/2 at various meiotic stages after GVBD when microtubule began to organize. Also, Plk1 was able to coimmunoprecipitate with p-MEK1/2 in metaphase I stage mouse oocyte extracts, further confirming their physical interaction. Taxol-treated oocytes exhibited a number of cytoplasmic asters, in which both Plk1 and p-MEK1/2 were present, indicating that they might be complexed to participate in the acentrosomal spindle formation at the MTOCs during oocyte meiosis. Depolymerization of microtubules by nocodazole resulted in the complete disassembly of spindles, but Plk1 remained associated with p-MEK1/2, accumulating in the vicinity of chromosomes. More importantly, when p-MEK1/2 activity was blocked by U0126, Plk1 lost its normal localization at the spindle poles, which might be one of the most vital factors causing the abnormal spindles in MEK1/2-inhibited oocytes. Taken together, these data indicate that Plk1 and MEK1/2 regulate the spindle formation in the same pathway and that Plk1 is involved in MEK1/2-regulated spindle assembly during mouse oocyte meiotic maturation.
Subject(s)
Cell Cycle Proteins/physiology , MAP Kinase Kinase 1/metabolism , MAP Kinase Kinase 2/metabolism , Meiosis , Oocytes/enzymology , Protein Serine-Threonine Kinases/physiology , Proto-Oncogene Proteins/physiology , Spindle Apparatus/enzymology , Animals , Cell Cycle Proteins/analysis , Female , Immunoprecipitation , MAP Kinase Kinase 1/analysis , MAP Kinase Kinase 2/analysis , Mice , Microtubule-Organizing Center/enzymology , Nocodazole/pharmacology , Oocytes/drug effects , Protein Serine-Threonine Kinases/analysis , Proto-Oncogene Proteins/analysis , Spindle Apparatus/ultrastructure , Tubulin Modulators/pharmacology , Polo-Like Kinase 1ABSTRACT
Isolation and dissection of native multiprotein complexes is a central theme in functional genomics. The development of the tandem affinity purification (TAP) tag has enabled an efficient and large-scale purification of native protein complexes. However, the TAP tag features a size of 21 kDa and requires time consuming cleavage. By combining a tandem Strep-tag II with a FLAG-tag we were able to reduce the size of the TAP (SF-TAP) tag to 4.6 kDa. Both moieties have a medium affinity and avidity to their immobilised binding partners. This allows the elution of SF-tagged proteins under native conditions using desthiobiotin in the first step and the FLAG octapeptide in the second step. The SF-TAP protocol represents an efficient, fast and straightforward purification of protein complexes from mammalian cells within 2.5 h. The power of this novel method is demonstrated by the purification of Raf associated protein complexes from HEK293 cells and subsequent analysis of their protein interaction network by dissection of interaction patterns from the Raf binding partners MEK1 and 14-3-3.
Subject(s)
Chromatography, Affinity/methods , Multiprotein Complexes/chemistry , Multiprotein Complexes/isolation & purification , 14-3-3 Proteins/analysis , 14-3-3 Proteins/genetics , 14-3-3 Proteins/metabolism , Biotin/analogs & derivatives , Biotin/chemistry , Blotting, Western , Cell Line , Chromatography, High Pressure Liquid , Humans , MAP Kinase Kinase 1/analysis , MAP Kinase Kinase 1/genetics , MAP Kinase Kinase 1/metabolism , Oligopeptides/chemistry , Oligopeptides/genetics , Peptides/chemistry , Peptides/genetics , Proto-Oncogene Proteins B-raf/analysis , Proto-Oncogene Proteins B-raf/genetics , Proto-Oncogene Proteins B-raf/metabolism , Tandem Mass Spectrometry , TransfectionABSTRACT
Secreted factors present in the medium following growth of the periodontal pathogen Porphyromonas gingivalis cause increased cardiomyocyte hypertrophy and apoptosis, whereas secreted factors from Actinobacillus actinomycetemcomitans and Prevotella intermedia have no such effects. The purpose of this study was to clarify the role of mitogen-activated protein kinase (MAPK)/extracellular-regulated protein kinase (ERK) pathways in P. gingivalis medium-induced H9c2 myocardial cell hypertrophy and apoptosis. Cellular morphology, DNA fragmentation, nuclear condensation, total mitogen-activated protein kinase/extracellular-regulated protein kinase-1 (ERK-1), total ERK-1 protein, and phosphorylated ERK-1 protein products in cultured H9c2 myocardial cells were measured by actin immunofluorescence, agarose gel electrophoresis, nuclear condensation, and western blotting following stimulation with P. gingivalis spent growth medium or pre-administration of U0126, a potent MEK-1/2 inhibitor. Components of P. gingivalis spent culture medium not only resulted in increased total MEK-1 and ERK-1 protein products, but also caused increased cellular size, DNA fragmentation, and nuclear condensation in H9c2 cells. These three parameters, and the phosphorylated ERK-1 protein products of H9c2 cells treated with P. gingivalis medium, were all significantly reduced after pre-administration of U0126. The results suggest that P. gingivalis-secreted factors may initiate MEK/ERK signal pathways and lead to myocardial cell hypertrophy and apoptosis.
Subject(s)
Apoptosis/physiology , MAP Kinase Kinase 1/physiology , Myocytes, Cardiac/enzymology , Porphyromonas gingivalis/physiology , Animals , Blotting, Western , Butadienes/pharmacology , Cell Line , Cell Size , Culture Media, Conditioned , DNA Fragmentation , Electrophoresis, Agar Gel , Enzyme Inhibitors/pharmacology , Fluorescent Antibody Technique , Hypertrophy , Intranuclear Space/ultrastructure , MAP Kinase Kinase 1/analysis , MAP Kinase Kinase 1/antagonists & inhibitors , MAP Kinase Kinase 2/antagonists & inhibitors , Mitogen-Activated Protein Kinase 3/analysis , Mitogen-Activated Protein Kinase 3/antagonists & inhibitors , Mitogen-Activated Protein Kinase 3/physiology , Myocytes, Cardiac/microbiology , Nitriles/pharmacology , Rats , Signal Transduction/physiologyABSTRACT
Molecular profiling is a powerful approach to identify potential clinical markers for diagnosis and prognosis as well as providing a better understanding of the biology of epithelial ovarian cancer. On the basis of the analysis of HuFL expression data, we have previously identified genes that distinguish low malignant potential and invasive serous epithelial ovarian tumors. In this study, we used immunohistochemistry to monitor a subset of differently expressed candidates (Ahr, Paep, Madh3, Ran, Met, Mek1, Ccne1, Ccd20, Cks1 and Cas). A tissue array composed of 244 serous tumors of different grades (0-3) and stages (I-IV) was used in this analysis. All markers assayed presented differential protein expression between serous tumors of low and high grade. Significant differences in Ccne1 and Ran expression were observed in a comparison of low malignant potential and grade 1 tumor samples (p<0.01). In addition, irrespective of the grade, Ccne1, Ran, Cdc20 and Cks1 showed significant differences of expression in association with the clinical stage of disease. While high level of Ccne1 have previously been associated with poor outcomes, here we found that high level of either Ran or Cdc20 appear to be more tightly associated with a poor prognosis (p<0.001, 0.03, respectively). The application of these biomarkers in both the initial diagnosis and prognostic attributes of patients with epithelial ovarian tumors should prove to be useful in patient management.
Subject(s)
Biomarkers, Tumor/analysis , Cystadenocarcinoma, Serous/pathology , Ovarian Neoplasms/pathology , Tissue Array Analysis/methods , Basic Helix-Loop-Helix Transcription Factors , Biomarkers, Tumor/genetics , CDC2-CDC28 Kinases , Carrier Proteins/analysis , Carrier Proteins/genetics , Cdc20 Proteins , Cell Cycle Proteins/analysis , Cell Cycle Proteins/genetics , Cellular Apoptosis Susceptibility Protein/analysis , Cellular Apoptosis Susceptibility Protein/genetics , Cyclin E/analysis , Cyclin E/genetics , Cyclin-Dependent Kinases/analysis , Cyclin-Dependent Kinases/genetics , Cystadenocarcinoma, Serous/genetics , Cystadenocarcinoma, Serous/metabolism , Female , Gene Expression Profiling , Glycodelin , Glycoproteins/analysis , Glycoproteins/genetics , Humans , Immunohistochemistry , MAP Kinase Kinase 1/analysis , MAP Kinase Kinase 1/genetics , Middle Aged , Neoplasm Staging , Oligonucleotide Array Sequence Analysis , Oncogene Proteins/analysis , Oncogene Proteins/genetics , Ovarian Neoplasms/genetics , Ovarian Neoplasms/metabolism , Pregnancy Proteins/analysis , Pregnancy Proteins/genetics , Prognosis , Proto-Oncogene Proteins/analysis , Proto-Oncogene Proteins/genetics , Proto-Oncogene Proteins c-met , Receptors, Aryl Hydrocarbon/analysis , Receptors, Aryl Hydrocarbon/genetics , Receptors, Growth Factor/analysis , Receptors, Growth Factor/genetics , Smad3 Protein/analysis , Smad3 Protein/genetics , Survival Analysis , ran GTP-Binding Protein/analysis , ran GTP-Binding Protein/geneticsABSTRACT
OBJECTIVE: Application of heat shock before an inflammatory stimulus often results in an attenuated response to that stimulus. As a result, it has become increasingly appreciated that heat shock may induce cross-tolerance to a variety of stimuli based on in vitro and in vivo models. Circulating peripheral blood monocytes are key mediators of cytokine release following endotoxin challenge. The mitogen-activated protein kinases play a key role in the transcriptional regulation of this response including expression of tumor necrosis factor. As such, counterregulatory phosphatases that target mitogen-activated protein kinase may play a role in this heat shock-mediated effect. We hypothesized that prior heat shock to monocytes would induce a phosphatase, MKP-1, that regulated mitogen-activated protein kinase activity and subsequently conferred cross-tolerance to lipopolysaccharide stimulation. DESIGN: Experimental. SETTING: University research foundation laboratory. SUBJECTS: THP-1 human monocyte cell line. INTERVENTIONS: THP-1 cells were exposed to either heat shock (43 degrees C, 1 hr) or normothermia (37 degrees C, 1 hr) and allowed to recover before stimulation with endotoxin (lipopolysaccharide). MEASUREMENTS AND MAIN RESULTS: Induction of a heat shock response was determined by heat shock protein-70 expression. Tumor necrosis factor and interleukin-10 were measured by enzyme-linked immunosorbent assay to assess heat shock inhibition of lipopolysaccharide-induced gene expression. The effect of heat shock on lipopolysaccharide-mediated activation of the p38 and ERK kinases was examined by measuring phospho-specific isoforms of p38 and ERK1/2 and correlated to in vitro kinase activity. Confirmatory data were generated from experiments employing either pharmacologic inhibition or genetic deletion of MKP-1. Heat shock induced the nuclear localized phosphatase, MKP-1, that attenuated p38 and ERK kinase activity resulting in significantly diminished tumor necrosis factor expression in response to lipopolysaccharide. CONCLUSIONS: The effect of heat shock on decreasing the tumor necrosis factor response to lipopolysaccharide is conferred by induction of MKP-1, which negatively regulates p38 and ERK kinases. Modulation of phosphatase activity may be a potential strategy for attenuating acute inflammatory responses.